Vital Farms (NASDAQ:VITL – Free Report) had its target price cut by Needham & Company LLC from $45.00 to $35.00 in a report published on Monday,Benzinga reports. They currently have a buy rating on the stock.
Several other equities research analysts have also issued reports on the stock. Telsey Advisory Group dropped their price objective on shares of Vital Farms from $50.00 to $35.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. TD Cowen reiterated a “buy” rating on shares of Vital Farms in a report on Tuesday, January 20th. DA Davidson set a $47.00 price objective on Vital Farms and gave the company a “buy” rating in a research report on Wednesday, December 17th. Benchmark cut Vital Farms from a “buy” rating to a “hold” rating in a research note on Thursday, February 26th. Finally, Zacks Research lowered Vital Farms from a “strong-buy” rating to a “hold” rating in a research note on Friday, November 14th. Nine research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $45.00.
Get Our Latest Stock Report on VITL
Vital Farms Stock Performance
Vital Farms (NASDAQ:VITL – Get Free Report) last issued its earnings results on Thursday, February 26th. The company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.03). The firm had revenue of $213.55 million for the quarter, compared to analysts’ expectations of $212.83 million. Vital Farms had a return on equity of 20.69% and a net margin of 8.73%.The firm’s revenue for the quarter was up 28.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.23 EPS. Equities analysts anticipate that Vital Farms will post 1.11 earnings per share for the current year.
Insider Buying and Selling
In other news, CEO Russell Diez-Canseco sold 16,734 shares of the stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $35.05, for a total transaction of $586,526.70. Following the completion of the transaction, the chief executive officer directly owned 649,684 shares in the company, valued at approximately $22,771,424.20. This represents a 2.51% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, major shareholder Matthew Ohayer sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $20.33, for a total transaction of $406,600.00. Following the sale, the insider directly owned 6,321,190 shares of the company’s stock, valued at $128,509,792.70. The trade was a 0.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 86,734 shares of company stock valued at $2,498,827. 21.30% of the stock is owned by insiders.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the stock. Triumph Capital Management bought a new stake in shares of Vital Farms in the 4th quarter worth about $25,000. Quarry LP acquired a new position in Vital Farms in the fourth quarter worth about $27,000. Exchange Traded Concepts LLC acquired a new position in Vital Farms in the third quarter worth about $28,000. Global Retirement Partners LLC increased its holdings in Vital Farms by 4,382.6% in the fourth quarter. Global Retirement Partners LLC now owns 1,031 shares of the company’s stock valued at $33,000 after buying an additional 1,008 shares during the last quarter. Finally, PNC Financial Services Group Inc. raised its stake in Vital Farms by 225.6% during the fourth quarter. PNC Financial Services Group Inc. now owns 1,452 shares of the company’s stock valued at $46,000 after buying an additional 1,006 shares in the last quarter. 98.59% of the stock is owned by institutional investors and hedge funds.
Vital Farms News Roundup
Here are the key news stories impacting Vital Farms this week:
- Positive Sentiment: Analysts’ consensus still shows some support — a recent aggregator noted a “Moderate Buy” consensus from analysts, which could provide buying interest if sentiment stabilizes. Analyst Consensus: Moderate Buy
- Positive Sentiment: Some Wall Street commentary highlights bulls and reasons to consider the stock, which may attract opportunistic investors if shares overshoot to the downside. Wall Street Bulls Look Optimistic
- Neutral Sentiment: Insider transaction — major shareholder Matthew Ohayer sold 20,000 shares at about $20.33 (≈$406.6K). The sale is small relative to his ~6.32M share holding (≈0.32% reduction), so it’s a modest signal rather than a large forced liquidation. SEC Filing: Insider Sale
- Negative Sentiment: Rosen Law Firm announced a securities‑class‑action investigation alleging Vital Farms may have provided materially misleading information to investors — such probes can increase legal risk, potential liabilities and near‑term headline volatility. Rosen Law Firm Investigation
- Negative Sentiment: Zacks Research downgraded Vital Farms from “Hold” to “Strong Sell,” which can accelerate outflows from model‑based funds and momentum traders. Zacks Downgrade
- Negative Sentiment: Broker downgrades and lowered forecasts — Needham and Mizuho have reduced expectations for Vital Farms, and Benchmark cut to Hold and removed its price target after the company issued a “volatile” Q1 outlook. These analyst moves increase sell‑side pressure and signal uncertainty around near‑term revenue/earnings momentum. Needham Outlook
- Negative Sentiment: Mizuho lowered expectations as well, compounding the negative analyst trend and likely contributing to shorter‑term downside. Mizuho Lowers Expectations
- Negative Sentiment: Benchmark’s downgrade tied to a cautious Q1 outlook — the firm cited tempered FY26 revenue growth and removed its price target, reinforcing recessionary/volume risk concerns that can pressure valuation multiples. Benchmark Downgrade
About Vital Farms
Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.
Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.
Featured Articles
- Five stocks we like better than Vital Farms
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Vital Farms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vital Farms and related companies with MarketBeat.com's FREE daily email newsletter.
